Bioworld Financial Watch articles from September 2002

Bioworld Financial Watch archives from September 2002

Summer of discontent ending; industry aims for fal revival.
September 2, 2002... Talk to enough buy-side analysts and industry boosters, and you're likely to come away with a strangely weary feeling. It's a feeling behind which lies suspicion and skepticism, a grave doubt about even the possibility of optimism. Phrases...

Money raised by biotech in 2002 Vs. 2001.
September 2, 2002... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1 - August 28, Jan. 1 - August 29, 2002: $8,213.76M 2001: $7,995M Public/Other * 4,876...

10 biggest U.S. gainers for the week.
September 2, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Genelabs 63.01 Demegen 42.86 Genaera 35.00 Texas Biotech 34.21 Cell Pathways 32.56 Transgenomic 25.16 InterMune 23.49 BioCryst 21.62...

10 biggest U.S. losser for the week.
September 2, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Sheffield -33.33 Photogen -32.22 Ista Phanna -27.27 Lynx Therapeutics -26.40 Valentis -25.40 Synsorb Biotech -23.33 Helix Biomed ...

U.S. public offering performance by underwriter: Jan. 1 - July 31, 2002.
September 2, 2002... U.S. Public Offering Performance By Underwriter: Jan. 1 - July 31, 2002 * UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - JULY 31, 2002: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter ...

Underwriters' performance on all public offerings Jan. 1 - July 31, 2002: full credit to all underwriters, ranked by after-market performance.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - JULY 31, 2002: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE * # Underwriter (Number Of Offerings As Lead/ After-Market Number Of Offerings...

Underwriters' performance on IPOS from Jan. 1, 2002, to July 31, 2002: full credit to lead underwriter, ranked by gross proceeds.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2002, TO JULY 31, 2002: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of IPOs As Proceeds Lead...

Underwriters' performance on IPOS from Jan. 1, 2002, to July 31, 2002: full credit to lead underwriter, ranked by after - market performance.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2002, TO JULY 31, 2002: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER- MARKET PERFORMANCE # Underwriter After-Market (Number Of IPOs As ...

Underwriters' performance on IPOS from Jan. 1, 2002, to July 31, 2002: full credit to all underwriters, ranked by gross proceeds.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2002, TO JULY 31, 2002: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of IPOs As Lead/Number Proceeds Of...

Underwriters' performance on IPOS from Jan. 1, 2002 to July 31, 2002: full credit to all underwriters, ranked by after - market performance.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2002 TO JULY 31, 2002: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER- MARKET PERFORMANCE # Underwriter After-Market (Number Of IPOs As Lead/Number ...

Underwriters' performance on all public offerings from Jan. 1, 2002, to July 31, 2002: full credit to lead underwriter, ranked by gross proceeds.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2002, TO JULY 31, 2002: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of Offerings As ...

Underwriters' performance on all public offerings from Jan. 1, 2002, to July 31, 2002: full credit to lead underwriter, ranked by after - market performace.
September 2, 2002... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2002, TO JULY 31, 2002: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE # Underwriter After-Market (Number Of Offerings As ...

BioWorld stock report for public biotechnology companies.
September 2, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 8/23 8/30 WK YTD 3D Pharma DDDP 3.13 3.19 ...

London stock exchange.
September 2, 2002... LONDON STOCK EXCHANGE Company Symbol 8/23 8/30 %WK %YTD Volume Acambis ACM 284 277.5 -2.29 -20.83 2250 Antisoma ASM 16.75 16 -4.48 -54.93 488 British Biotech BBG...

Toronto stock exchange.
September 2, 2002... TORONTO STOCK EXCHANGE Company Symbol 8/23 8/30 %WK %YTD Volume Adherex AHX 0.35 0.4 14.29 -4.76 271 Angiotech Pharma ANP 70.3 70.2 -0.14 -21.12 42 Anormed ...

As clock ticks for Avastin data, Genentech faces filing decision.
September 9, 2002... The climate may cool with September's advent, but the industry late last week was still expecting a blast of potentially hot autumnal news about Phase III trials of Genentech Inc.'s monoclonal antibody Avastin (bevacizumab) in combination with...

Money raised by biotech.
September 9, 2002... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1 - Sept. 5, Jan. 1 - Sept. 6, 2002: $8,249.26M 2001: $8,108M Public/Other * 4,877 ...

10 biggest U.S. gainers for the week.
September 9, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Paradigm Genetics 118.18 Synsorb Biotech 63.04 Triangle Pharma 30.46 Miravant 26.92 OXiGENE 26.67 AVI BioPharma 25.92 eXegenics ...

10 biggest U.S. losers for the week.
September 9, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Nexell -44.44 NeoTherapeutics -32.27 Genelabs -28.40 Cel-Sci -24.24 Northwest BioThera -22.73 Valentis -21.28 Ribozyme...

Public financing of biotechnology.
September 9, 2002... Public Financing Of Biotechnology: August 2002 I. COMMENCED TRADING IN AUGUST INITIAL OFFERINGS Company Date Date Shares/ Price (Symbol) # Filed Comm. Units (M) ...

Other financings of public biotechnology companies.
September 9, 2002... Other Financings Of Public Biotechnology Companies: August 2002 TOTAL: $83.771M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies.
September 9, 2002... Venture Capital And Corporate Investments In Biotechnology Companies: August 2002 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $198.914M Company Location Date Amt. (M) Alnylam Cambridge,...

BioWorld stock report for public biotechnology companies.
September 9, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 8/30 9/6 WK YTD 3D Pharma DDDP 3.19 3.16...

London stock exchange.
September 9, 2002... LONDON STOCK EXCHANGE Company Symbol 8/30 9/6 %WK %YTD Volume * Acambis ACM 277.5 235 -15.32 -32.95 2055 Antisome ASM 16 13.5 -15.63 -61.97 559 British Biotech ...

Toronto stock exchange.
September 9, 2002... TORONTO STOCK EXCHANGE Company Symbol 8/30 9/6 %WK %YTD Volume * Adherex AHX 0.4 0.45 12.50 7.14 237 Angiotech Pharma ANP 70.2 69.69 -0.73 -21.70 34 Anormed...

'B' estrogen receptor approach gains ground in breast cancer.
September 16, 2002... With the dropping of the Avastin (bevacizumab) shoe last week--Genentech Inc. disclosed Phase III data showing the breast cancer drug missed its primary efficacy endpoint--came a renewed focus not only on vascular endothelial growth factor...

Money raised by biotech.
September 16, 2002... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1-Sept. 12, Jan. 1-Sept. 13, 2002: $8,315.93M 2002: $8,234M Public/Other * 4,881 2,773...

10 biggest U.S. gainers for the week.
September 16, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Ostex Int'l 80.91 Hybridon 41.79 Neurobio Tech 41.67 Nexell 40.00 SciClone 34.10 NeoPharm 32.70 Flamel Tech 25.69 British...

10 biggest U.S. losers for the week.
September 16, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Insmed -69.23 Axonyx -40.00 Synsorb Biotech -38.67 V.I. Technol -38.18 Neo Therapeutics -31.10 Cubist Pharma -30.88 Demegen ...

Clinical trial update: August 2002.
September 16, 2002... Clinical Trial Update: August 2002 Company * (Country; Symbol) Product Description AUTOIMMUNE Actelion Ltd. Tracleer Bosentan; orally active (Switzerland; (FDA-approved) endothelin...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: August 2002.
September 16, 2002... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 2002 Company * Product Description (Country; Symbol) AUTOIMMUNE SangStat RDP58 An...

FDA submissions, approvals and other actions: August 2002.
September 16, 2002... FDA Submissions, Approvals And Other Actions: August 2002 Company * Product Description (Country; Symbol) AUTOIMMUNE Genelabs Prestara Prasterone; the synthetic Technologies ...

BioWorld stock report for public biotechnology companies.
September 16, 2002... BioWold Stock Report For Public Biotechnology Companies Symbol Close Close % Change Vol Company 9/6 9/13 WK YTD (000) 3D Pharma DDDP 3.16 3 ...

London stock exchange.
September 16, 2002... LONDON STOCK EXCHANGE Company Symbol 9/6 9/13 % WK % YTD Volume Acambis ACM 235 248.5 5.74 -29.10 1828 Antisoma ASM 13.5 13.5 0.00 -61.97 2106 British Biotech BBG...

Toronto stock exchange.
September 16, 2002... TORONTO STOCK EXCHANGE Company Symbol 9/6 9/13 % WK % YTD Volume Adherex AHX 0.45 0.56 24.44 33.33 579 Angiotech Pharma ANP 69.69 67.6 -3.00 -24.04 67 Anormed ...

Genomics survival strategy: let pharma partners share risk.
September 23, 2002... ATLANTIC CITY, N.J. -- Cheerful hordes of excited people converged on this gambling city over the weekend for the annual Miss America pageant, with all of its royally sequined pomp and circumstance. But a few days earlier the tone was...

Money raised by biotech in 2002 Vs. 2001.
September 23, 2002... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1 - Sept. 19, Jan. 1 - Sept. 20, 2002: $8,401.83M 2001: $8,322M Public/Other * 4,945 ...

10 biggest U.S. gainers for the week.
September 23, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Ista Pharma 75.79 Curis 33.33 BioMarin 31.35 Oxis Int'l 25.00 Lynx Therapeutics 24.44 Genzyme 16.41 OXiGENE ...

10 biggest U.S. losers for the week.
September 23, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Biomira -60.25 Paradigm Genetics -47.02 EntreMed -42.86 Generex Biotech -37.44 British Biotech -35.00 Aphton -34.51 StemCells...

Biotech -- big pharma collaborations: new agreements, June 20 - Sept. 17, 2002.
September 23, 2002... Biotech -- Big Pharma Collaborations: New Agreements, June 20 - Sept. 17, 2002 # Biotech Co. * Pharma Co. (Country; (Country) Symbol) aaiPharma Inc. Tanabe...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: June 20 -- Sept. 17, 2002.
September 23, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: June 20 -- Sept. 17, 2002 # Biotech Co. * Pharma Co. (Country: (Country) Symbol) ...

Biotech -- big pharma collaborations: modified and terminated agreements, June 20 - Sept. 17, 2002.
September 23, 2002... Biotech -- Big Pharma Collaborations: Modified And Terminated Agreements, June 20 - Sept. 17, 2002 # I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. (Country; (Country) Symbol) ...

BioWorld stock report for public biotechnology companies.
September 23, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 9/13 9/20 WK YTD 3D Pharma DDDP 3 2.9 ...

London stock exchange.
September 23, 2002... LONDON STOCK EXCHANGE Company Symbol 9/13 9/20 %WK %YTD Volume Acambis ACM 248.5 225 -9.46 -35.81 1394 Antisoma ASM 13.5 12.5 -7.41 -64.79 2125 British Biotech BBG...

Toronto stock exchange.
September 23, 2002... TORONTO STOCK EXCHANGE Company Symbol 9/13 9/20 %WK %YTD Volume Adherex AHX 0.56 0.57 1.79 35.71 147 Angiotech Pharma ANP 67.6 64.46 -4.64 -27.57 185 Anormed ...

Genzyme/TKT panel meeting stalls, but interest builds in 'LSD' drugs.
September 30, 2002... LSD, still best known as the acronym for the once-popular hippie drug lysergic acid diethylamide, also is recognized to stand for something else in the pharmaceutical world. And that something may be just what the doctor ordered for those who...

Money raised by biotech in 2002 vs. 2001.
September 30, 2002... Money Raised by Biotech In 2002 Vs. 2001 Millions Jan. 1 - Sept. 26, Jan. 1 - Sept. 27, 2002: $8,586.01M 2001: $8,429M Public/Other * 4,951 ...

10 biggest U.S. gainers for the week.
September 30, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Miravant 45.16 Curis 38.10 ViroLogic 33.33 AEterna 31.71 InSite Vision 26.32 DeCode 27.71 Demegen ...

10 biggest U.S. losers for the week.
September 30, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) NaPro Biother -37.74 Genaissance -33.86 Pain Therapeu -33.84 Ribozyme -32.76 SuperGen -32.58 Medarex -30.02 NeoRx Corp. ...

Biotechnology company deals with other Biotechnology companies: collaborations, agreements, equity participation.
September 30, 2002... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, July 26 - Sept. 24, 2002 # Company * Company * (Country; (Country;...

Biotechnology company deals with Miscellaneous companies: collaborations, agreement, equity participation.
September 30, 2002... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreement, Equity Participation, July 26 -- Sept. 24, 2002 # Company * Company * (Country; (Country) Symbol) Agilent...

Manufacturing, marketing and distribution agreements between biotech companies.
September 30, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: July 26 - Sept. 24, 2002 # Company * Company * (Country; (Country; Symbol) Symbol) ...

Biotech--biotech collaborations: modified and terminated agreements.
September 30, 2002... Biotech -- Biotech Collaborations: Modified And Terminated Agreements, July 26 -- Sept. 24, 2002 # Company * Company * (Country; (Country; Symbol) Symbol) I. MODIFIED...

BioWorld stock report for Public Biotechnology companies.
September 30, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 9/20 9/27 WK YTD 3D Pharma DDDP 2.9 2.969...

London Stock Exchange.
September 30, 2002... LONDON STOCK EXCHANGE Company Symbol 9/20 9/27 %WK %YTD Volume Acambis ACM 225 239 6.22 -31.81 1659 Antisoma ASM 12.5 11.75 -6.00 -66.90 197 British Biotech BBG...

Toronto Stock Exchange.
September 30, 2002... TORONTO STOCK EXCHANGE Company Symbol 9/20 9/27 %WK %YTD Volume Adherex AHX 0.57 0.43 -24.56 2.38 128 Angiotech Pharma ANP 64.46 63.14 -2.05 -29.06 295 Anormed ...